GGrantIndex
← Leaderboards

Arthi Kanthasamy

University Of Georgia

$7,127,865
Attributed
$9,663,114
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,663,114 · 8

By mechanism

R01$9,520,612 · 7
R03$142,502 · 1

Top collaborators

Most similar at University Of Georgia

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionMediatingMolecularNerve DegenerationCellsResponseNeuronsParkinson DiseaseNeuroinflammationAnimal ModelAffectNeuron LossStressNeurodegenerative DisordersBrainPathway InteractionsInsightBrain RegionMicrogliaCell Culture TechniquesNeurotoxicNeurochemistryNovel Therapeutic InterventionInflammatory

Grant awards (29)

Novel Epitranscriptomic Mechanisms in Metal Neurotoxicity$441,529
R01 · FY2025 · ES
Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD$436,013
R01 · FY2025 · NS
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis$382,212
R01 · FY2025 · NS · contact PI
Role of Prokineticin 2 in Metal Neurotoxicity$339,750
R01 · FY2025 · ES
Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD$422,932
R01 · FY2024 · NS
Role of Prokineticin 2 in Metal Neurotoxicity$339,750
R01 · FY2024 · ES
Role of Prokineticin 2 in Metal Neurotoxicity$331,166
R01 · FY2024 · ES
Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD$436,013
R01 · FY2023 · NS
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis$383,147
R01 · FY2023 · NS · contact PI
Role of Prokineticin 2 in Metal Neurotoxicity$339,750
R01 · FY2023 · ES
Compensatory Mitochondrial Protective Mechanisms Against Oxidative Stress in PD$436,013
R01 · FY2022 · NS
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis$384,050
R01 · FY2022 · NS · contact PI
The Role of KCa3.1 in Microglial function and in Parkinsons disease pathogenesis$398,173
R01 · FY2021 · NS · contact PI
Exosomes and Neuroinflammation in Parkinsons Disease$319,735
R01 · FY2019 · NS · contact PI
Exosomes and Neuroinflammation in Parkinsons Disease$319,924
R01 · FY2018 · NS · contact PI
Exosomes and Neuroinflammation in Parkinsons Disease$320,255
R01 · FY2017 · NS · contact PI
Exosomes and Neuroinflammation in Parkinsons Disease$320,572
R01 · FY2016 · NS · contact PI
Prokineticin 2 and Neuroinflammatory Mechanisms$317,965
R01 · FY2016 · NS · contact PI
Exosomes and Neuroinflammation in Parkinsons Disease$320,876
R01 · FY2015 · NS · contact PI
Prokineticin 2 and Neuroinflammatory Mechanisms$318,198
R01 · FY2015 · NS · contact PI
Prokineticin 2 and Neuroinflammatory Mechanisms$315,344
R01 · FY2014 · NS · contact PI
Prokineticin 2 and Neuroinflammatory Mechanisms$307,265
R01 · FY2013 · NS · contact PI
Prokineticin 2 and Neuroinflammatory Mechanisms$318,842
R01 · FY2012 · NS · contact PI
Neuroinflammatory Mechanisms in the Progression of Parkinson's Disease$315,237
R01 · FY2012 · NS · contact PI
Neuroinflammatory Mechanisms in the Progression of Parkinson's Disease$315,355
R01 · FY2011 · NS · contact PI
Neuroinflammatory Mechanisms in the Progression of Parkinson's Disease$318,624
R01 · FY2010 · NS · contact PI
Neuroinflammatory Mechanisms in the Progression of Parkinson's Disease$321,922
R01 · FY2009 · NS · contact PI
Oxidative Stress, PKC-delta Activation and Striatal Ischemic Cell Death$69,738
R03 · FY2007 · NS · contact PI
Oxidative Stress, PKC-delta Activation and Striatal Ischemic Cell Death$72,764
R03 · FY2006 · NS · contact PI